Article info
PDFSection 4: Clinical Pharmacy Services
4CPS-133 Daratumumab (darzalex) for the treatment of multiple myeloma in a third-level hospital: variability of use and effectiveness
Citation
4CPS-133 Daratumumab (darzalex) for the treatment of multiple myeloma in a third-level hospital: variability of use and effectiveness
Publication history
- First published March 11, 2019.
Online issue publication
May 12, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions